在多药耐药时代处理肺移植中的抗生素预防:米兰算法
Andrea Lombardi1, Davide Mangioni2, Giulia Renisi2
1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Transplantation proceedings
|January 9, 2025
概括
感染性并发症是肺移植 (LuTx) 后的主要威胁. 多重PCR测试为快速鉴定病原体和向抗生素治疗以对抗抗菌素耐药性 (AMR) 提供了一个有希望的方法.
科学领域:
- 医学微生物学 医学微生物学
- 移植手术 移植手术
- 传染性疾病 传染性疾病
背景情况:
- 感染性并发症是肺移植 (LuTx) 后死亡的主要原因,占死亡率的25%以上.
- 目前的抗生素预防实践,特别是对多药耐药生物体 (MDROs) 的预防实践,是不一致的,并导致免疫受损患者对抗菌素耐药性 (AMR) 的担忧.
研究的目的:
- 探索综合症多重聚合酶连锁反应 (mPCR) 试验在肺移植中的潜力.
- 评估mPCR对快速发现病原体和耐药机制的有用性,以指导向的抗菌疗法.
主要方法:
- 对肺移植的抗生素预防现行实践的审查.
- 讨论综合多重PCR (mPCR) 在LuTx环境中的潜在应用和局限性.
主要成果:
- 传染性并发症显著增加肺移植接受者的发病率和死亡率.
- 广泛的抗生素使用引发了关于抗菌素耐药性 (AMR) 的担忧.
- 综合征性mPCR测试可以同时检测多种病原体和耐药机制,从而实现更快,更有针对性的治疗.
结论:
- 以mPCR等快速诊断为指导的向抗菌疗法对于治疗肺移植受体感染至关重要.
- 需要进一步的研究和mPCR的临床整合,以优化结果和打击LuTx中的AMR.
- 通过先进的诊断来解决传染性并发症对于改善肺移植生存率至关重要.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177


